GlaxoSmithKline/GSK

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1YMAX

About GlaxoSmithKline

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Ticker

GSK

Sector

Healthcare

Trading on

LSE

Industry

Pharmaceuticals

Headquarters

Brentford, United Kingdom

Employees

70,212

GlaxoSmithKline Metrics

BasicAdvanced
£61B
Market cap
13.82
P/E ratio
£1.09
EPS
0.27
Beta
£0.59
Dividend rate
3.92%
Dividend yield
£61B
0.27
£0.59
0.867
0.574
114.566
134.341
50.40%
12.93%
9.32%
38.78%
13.82
1.99
4.43
-6.96
11.45
3.92%
5.69%
-69.60%
0.63%
-5.81%
-16.13%

What the Analysts think about GlaxoSmithKline

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for GlaxoSmithKline stock.

GlaxoSmithKline Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

GlaxoSmithKline Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

Jul
11
GlaxoSmithKline
Dividend·Payment
£0.15
Per share

FAQs

What’s the current market cap for GlaxoSmithKline stock?

GlaxoSmithKline (GSK) has a market cap of £61B as of July 03, 2024.

What is the P/E ratio for GlaxoSmithKline stock?

The price to earnings (P/E) ratio for GlaxoSmithKline (GSK) stock is 13.82 as of July 03, 2024.

Does GlaxoSmithKline stock pay dividends?

Yes, the GlaxoSmithKline (GSK) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is £0.59 and the yield is 3.92%. GlaxoSmithKline has a payout ratio of 50.4% on a trailing twelve-month basis.

When is the next GlaxoSmithKline dividend payment date?

The next GlaxoSmithKline (GSK) dividend payment is scheduled for July 11, 2024.

What is the beta indicator for GlaxoSmithKline?

GlaxoSmithKline (GSK) has a beta rating of 0.27. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell GlaxoSmithKline stock

Buy or sell GlaxoSmithKline stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing